These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition by rapamycin of PDGF- and bFGF-induced human tenon fibroblast proliferation in vitro. Salas-Prato M; Assalian A; Mehdi AZ; Duperré J; Thompson P; Brazeau P J Glaucoma; 1996 Feb; 5(1):54-9. PubMed ID: 8795734 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of T and B lymphocyte proliferation by rapamycin. Kay JE; Kromwel L; Doe SE; Denyer M Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916 [TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose rapamycin on tumor growth in two human hepatocellular cancer cell lines. Heuer M; Benkö T; Cicinnati VR; Kaiser GM; Sotiropoulos GC; Baba HA; Treckmann JW; Broelsch CE; Paul A Transplant Proc; 2009; 41(1):359-65. PubMed ID: 19249557 [TBL] [Abstract][Full Text] [Related]
12. [Fetal human myocardium. Proliferation of the myocytes and development of the cardiac interstitium in the last two gestational trimesters]. dos Santos MB; Mandarim-de-Lacerda CA Arq Bras Cardiol; 1997 Feb; 68(2):99-102. PubMed ID: 9433834 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin impairs in vivo proliferation of islet beta-cells. Zahr E; Molano RD; Pileggi A; Ichii H; Jose SS; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L Transplantation; 2007 Dec; 84(12):1576-83. PubMed ID: 18165767 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin impairs beta-cell proliferation in vivo. Zahr E; Molano RD; Pileggi A; Ichii H; San Jose S; Bocca N; An W; Gonzalez-Quintana J; Fraker C; Ricordi C; Inverardi L Transplant Proc; 2008 Mar; 40(2):436-7. PubMed ID: 18374093 [TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells. Adkins JR; Castresana MR; Wang Z; Newman WH Am Surg; 2004 May; 70(5):384-7; discussion 387-8. PubMed ID: 15156944 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083 [TBL] [Abstract][Full Text] [Related]
17. Trk C receptor signaling regulates cardiac myocyte proliferation during early heart development in vivo. Lin MI; Das I; Schwartz GM; Tsoulfas P; Mikawa T; Hempstead BL Dev Biol; 2000 Oct; 226(2):180-91. PubMed ID: 11023679 [TBL] [Abstract][Full Text] [Related]
18. Possible mechanism by which rapamycin increases cyclosporine nephrotoxicity. Cheng CH; Chang HR; Chiang CW; Shu KH; Chou MC Transplant Proc; 2008 Sep; 40(7):2373-5. PubMed ID: 18790238 [TBL] [Abstract][Full Text] [Related]
19. New advances in antirejection therapy. Chan M; Pearson GJ Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990 [TBL] [Abstract][Full Text] [Related]
20. Rapamycin-induced phosphaturia. Kempe DS; Dërmaku-Sopjani M; Fröhlich H; Sopjani M; Umbach A; Puchchakayala G; Capasso A; Weiss F; Stübs M; Föller M; Lang F Nephrol Dial Transplant; 2010 Sep; 25(9):2938-44. PubMed ID: 20368307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]